ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Chandan Healthcare Earnings Call: Key Takeaways

Chandan Healthcare delivered robust FY26 growth, pivoting from a regional player to a pan-India diagnostic platform. Management remains aggressively optimistic about franchise scaling and government PPP projects despite high capital intensity.

Highlights
Revenue growthFY26 revenue up 20.43% YoY to ₹280.67 crore.
MarginsEBITDA margin up 164 bps to 20.25%, masking 40% diagnostic margins.
Order bookFive PPP projects secured, estimated at ₹800 crore over 10 years.
Demand visibilityStrong, driven by pan-India expansion and multi-state PPP projects.
Management confidenceExtremely optimistic, emphasizing aggressive geographical expansion and scalable platforms.

Growth

FY26 revenue grew 20.4% to ₹280.67cr; B2B segment surged an impressive 50% year-on-year.

Outlook

Targeting 1,000 operational franchises within 24 months and 40% diagnostic EBITDA margins once centers mature.

Risks

High receivables from government projects (up to 6 months) and heavy expansion capex pressure overall margins.

Source

Earnings Call filed with NSE, NSE: CHANDAN. Summary written with AI assistance from the document.

Read the document ↗

Chandan Healthcare Ltd: key numbers

Share price
₹238.00
Market cap
₹611.7 Cr
Revenue (annual)
₹276.4 Cr
Net profit (annual)
₹27.06 Cr
P/E (TTM)
22.6×Sector 54.5×
Promoter holding
47.20%-2.41% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Chandan Healthcare Ltd

All →